1 - 20 of about 51
English: Hiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, Kensuke Usuki, Hideo Tanaka, Masaya Okada, Shugo Kowata, Kazunori Murai, Asao Hirose, Motohiro Shindo, Takashi Kumagai, Tomoharu Takeoka, Kazuharu Kamachi, Keisuke Kidoguchi, Takero Shindo, Satoshi Iyama, Junki Inamura, Takafumi Nakao, Tsutomu Kobayashi, Eri Kawata,Shinya Kimura, KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC Trial, a multicenter Observational Study , Blood Neoplasia , vol.1 (1) (p.1 - 8) , 2024
English: Yamamoto M, Shindo M, Funayama T, Sumi C, Saito T, Toki Y, Hatayama M, Ono Y, Sato K, Mizukami Y, Okumura T. , Monitoring mutant KRAS in plasma cell-free DNA can predict disease progression in a patient with multiple myeloma: A case report. , Clin Chim Acta. , vol.551 (p.117590 - ) , 2023 , (IF:3.79)
English: Igarashi S, Nozu T, Ishioh M, Funayama T, Sumi C, Saito T, Toki Y, Hatayama M, Yamamoto M, Shindo M, Tanabe H, Okumura T., Ghrelin prevents lethality in a rat endotoxemic model through central effects on the vagal pathway and adenosine A2B signaling : Brain ghrelin and anti-septic action. , Journal of Physiology and Biochemistry , vol.79 (3) (p.625 - 634) , 2023 , (IF:4.16)
English: Funayama T, Nozu T, Ishioh M, Igarashi S, Sumi C, Saito T, Toki Y, Hatayama M, Yamamoto M, Shindo M, Tanabe H, Okumura T. , Centrally administered GLP-1 analogue improves intestinal barrier function through the brain orexin and the vagal pathway in rats. , Brain Res. , vol.1809 (p.148371 - ) , 2023 , (IF:3.25)
English: Sato K, Igarashi S, Tsukada N, Inamura J, Yamamoto M, Shindo M, Moriichi K, Mizukami Y, Fujiya M, Torimoto Y., Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation , BMC Cancer , vol.22 (1) (p.944 - ) , 2022 , (IF:4.638)
English: Yamamoto M, Shindo M, Funayama T, Sumi C, Saito T, Toki Y, Hatayama M, Imadome KI, Mizukami Y, Okumura T., Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report. , Medicine (Baltimore) , vol.101 (12) (p.e29055 - ) , 2022 , (IF:1.889)
English: Takatsuki M, Natsuda K, Hidaka M, Sawada K, Shindo M, Endo T, Hagiwara T, Yotsuyanagi H, Koibuchi T, Tsukada K, Uemura H, Hayashi K, Uehira T, Mita E, Yamamoto M, Takahama S, Eguchi S. , The treatment choices and outcome of hepatocellular carcinoma in hemophilic patients with human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfection due to contaminated blood products in Japan. , J Gastrointest Oncol. , vol.12 (6) (p.2952 - 2959) , 2021 , (IF:2.89)
English: Yamamoto M, Shindo M, Sumi C, Igarashi S, Saito T, Tsukada N, Toki Y, Hatayama M, Inamura J, Sato K, Mizukami Y, Torimoto Y, Okumura T. , Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report , Medicine (Baltimore) , vol.100 (16) (p.e25518 - ) , 2021 , (IF:1.552)
English: Sato K, Tsukada N, Inamura J, Komatsu S, Sato K, Yamamoto M, Shindo M, Moriichi K, Mizukami Y, Fujiya M, Torimoto Y, Okumura T. , Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine , Case Reports in Hematology (p.640597 - ) , 2021
English: Igarashi S, Nozu T, Ishioh M, Kumei S, Saito T, Toki Y, Hatayama M, Yamamoto M, Shindo M, Tanabe H, Okumura T., Centrally administered orexin prevents lipopolysaccharide and colchicine induced lethality via the vagal cholinergic pathway in a sepsis model in rats , Biochemical Pharmacology , vol.182 (p.114262 - ) , 2020 , (IF:4.96)
English: Mori T, Shiratori S, Suzumiya J, Kurokawa M, Shindo M, Naoyuki U, Katsuto T, Miyamoto T, Morishige S, Hirokawa M, Fukuda T, Atsuta Y, Suzuki R., Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome. , Hematological Oncology , vol.38 (3) (p.266 - 271) , 2020 , (IF:5.271)
English: Kimura S, Imagawa J, Murai K, Hino M, Kitawaki T, Okada M, Tanaka H, Shindo M, Kumagai T, Ikezoe T, Uoshima N, Sato T, Watanabe R, Kowata S, Hayakawa M, Hosoki T, Ikeda K, Kobayashi T, Kakinoki Y, Nishimoto T, Takezako N, Shibayama H, Takaori-Kondo A, Nakamae H, Kawaguchi A, Ureshino H, Sakamoto J, Ishida Y; DADI Trial Group., Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial. , The Lancet Haematology , vol.7 (3) (p.e218 - e225) , 2020 , (IF:10.406)
English: Fukano R, Mori T, Fujita N, Kobayashi R, Mitsui T, Kato K, Suzuki R, Suzumiya J, Fukuda T, Shindo M, Maseki N, Shimoyama T, Okada K, Inoue M, Inagaki J, Hashii Y, Sato A, Tabuchi K., Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma. , International Journal of Hematology , vol.110 (6) (p.723 - 728) , 2019
English: Maruyama K, Nakagawa N, Suzuki A, Kabara M, Matsuki M, Shindo M, Iwasaki S, Ogawa Y, Hasebe N., Novel Detection of CALR-Mutated Cells in Myeloproliferative Neoplasm-Related Glomerulopathy With Interstitial Extramedullary Hematopoiesis: A Case Report. , American Journal of Kidney Diseases , vol.74 (6) (p.844 - 848) , 2019
English: Yamamoto M, Ikuta K, Sawada K, Shindo M, Torimoto Y, Okumura T., Hepatitis B virus (HBV) reactivation in an acute lymphoblastic leukemia patient despite being vaccinated against HBV in infancy. , Digestive and Liver Disease , vol.51 (10) (p.1487 - 1488) , 2019
English: Kondo T, Fujioka M, Fujisawa S, Sato K, Tsuda M, Miyagishima T, Mori A, Iwasaki H, Kakinoki Y, Yamamoto S, Haseyama Y, Ando S, Shindo M, Ota S, Kurosawa M, Ohba Y, Teshima T; North Japan Hematology Study Group (NJHSG)., Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test. , International Journal of Hematology , vol.110 (4) (p.482 - 489) , 2019
English: Ota S, Matsukawa T, Yamamoto S, Shinichi I, Shindo M, Sato K, Kondo T, Kohda K, Sakai H, Mori A, Takahashi T, Ikeda H, Kuroda H, Haseyama Y, Yamamoto M, Sarashina T, Yoshida M, Kobayashi R, Nishio M, Ishihara T, Hirayama Y, Kakinoki Y, Kobayashi H, Fukuhara T, Imamura M, Kurosawa M., Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic phase chronic myeloid leukemia. , European Journal of Haematology , vol.101 (1) (p.95 - 105) , 2018 , (IF:2.653)
English: Hatayama M, Ikuta K, Ishioh M, Saito T, Toki Y, Yamamoto M, Shindo M, Torimoto Y, Okumura T., Pseudogout Attack after Pegfilgrastim Administration in Anaplastic Large Cell Lymphoma. , Internal Medicine , vol.57 (12) (p.1779 - 1782) , 2018 , (IF:0.904)
English: Maruyama K, Nakagawa N, Suzuki A, Kabara M, Matsuki M, Shindo M, Ogawa Y, Hasebe N., Pazopanib-induced Endothelial Injury with Podocyte Changes. , Internal Medicine , vol.57 (7) (p.987 - 991) , 2017 , (IF:0.817)
English: Murai K, Yamaguchi K, Ito S, Miyagishima T, Shindo M, Wakasa K, Inomata M, Nagashima T, Kondo T, Fujimoto N, Yamamoto S, Yonezumi M, Oyake T, Kowata S, Tsukushi Y, Mine T, Meguro K, Ikeda K, Watanabe R, Saito S, Sato S, Tajima K, Chou T, Kubo K, Oba K, Sakamoto J, Ishida Y, Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patients. , European Journal of Haematology , vol.100 (1) (p.27 - 35) , 2017 , (IF:2.653)
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.